These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The clinical benefits of the leukoreduction of blood products. Blajchman MA J Trauma; 2006 Jun; 60(6 Suppl):S83-90. PubMed ID: 16763486 [TBL] [Abstract][Full Text] [Related]
24. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy. Talmadge JE Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168 [TBL] [Abstract][Full Text] [Related]
25. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras. Xia G; Truitt RL; Johnson BD Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723 [TBL] [Abstract][Full Text] [Related]
26. Biologic effects of leukocytes present in transfused cellular blood products. Bordin JO; Heddle NM; Blajchman MA Blood; 1994 Sep; 84(6):1703-21. PubMed ID: 8080981 [TBL] [Abstract][Full Text] [Related]